AdvaMed Advancements / Emerging Policy Response Resources / Global & Trade / Tariffs

AdvaMed® Advancements: Q4 2025 Report

AdvaMed® Advancements: Q4 2025 Report highlights how unified industry advocacy responded to policy disruption, trade uncertainty, and federal action impacting medtech.

AdvaMed Advancements / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Advancements: Q3 2025 Report

AdvaMed® Advancements: Q3 2025 Report. Amid an increasingly charged political environment,AdvaMed® remained a steady, persuasive voice for medtech innovation. From mobilizing rapid action on the Section 232 investigation to advancing…

AdvaMed Advancements / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs

AdvaMed® Advancements: Q2 2025 Report

Discover our Q2 report highlighting key industry wins, tariff updates, and strategic progress driving medtech innovation and advocacy forward.

Tablet displaying cover of AdvaMed®'s "Annual Report: 2024 Year in Review" with a blue abstract background.
AdvaMed Advancements

2024 Annual Report

Explore AdvaMed®’s key achievements and milestones in 2024 on behalf of our member companies and the patients they serve.